Idorsia Ltd (IDIA.SW)
CHF 1.3
(2.45%)
CHF 1.3
(2.45%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 499.99 Million CHF | -44.7% |
| 2022 | 904.18 Million CHF | -39.03% |
| 2021 | 1.48 Billion CHF | 3.32% |
| 2020 | 1.43 Billion CHF | 42.94% |
| 2019 | 1 Billion CHF | -28.62% |
| 2018 | 1.4 Billion CHF | 8.89% |
| 2017 | 1.29 Billion CHF | 41.17% |
| 2016 | 915.12 Million CHF | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 670.06 Million CHF | -14.16% |
| 2024 Q1 | 780.58 Million CHF | 56.12% |
| 2024 Q3 | 432.6 Million CHF | -35.44% |
| 2023 Q3 | 653.12 Million CHF | 23.75% |
| 2023 Q4 | 499.99 Million CHF | -23.45% |
| 2023 FY | 499.99 Million CHF | -44.7% |
| 2023 Q1 | 698.36 Million CHF | -22.76% |
| 2023 Q2 | 527.76 Million CHF | -24.43% |
| 2022 Q2 | 1.05 Billion CHF | -15.7% |
| 2022 Q4 | 904.18 Million CHF | -11.77% |
| 2022 FY | 904.18 Million CHF | -39.03% |
| 2022 Q1 | 1.25 Billion CHF | -15.25% |
| 2022 Q3 | 1.02 Billion CHF | -3.27% |
| 2021 Q1 | 1.29 Billion CHF | -9.58% |
| 2021 FY | 1.48 Billion CHF | 3.32% |
| 2021 Q4 | 1.48 Billion CHF | -11.63% |
| 2021 Q3 | 1.67 Billion CHF | 41.44% |
| 2021 Q2 | 1.18 Billion CHF | -8.58% |
| 2020 FY | 1.43 Billion CHF | 42.94% |
| 2020 Q1 | 881.75 Million CHF | -12.19% |
| 2020 Q2 | 1.15 Billion CHF | 31.43% |
| 2020 Q3 | 1.04 Billion CHF | -9.49% |
| 2020 Q4 | 1.43 Billion CHF | 36.85% |
| 2019 Q2 | 1.26 Billion CHF | -7.35% |
| 2019 FY | 1 Billion CHF | -28.62% |
| 2019 Q4 | 1 Billion CHF | -10.9% |
| 2019 Q1 | 1.36 Billion CHF | -3.27% |
| 2019 Q3 | 1.12 Billion CHF | -10.61% |
| 2018 Q1 | 1.19 Billion CHF | -7.13% |
| 2018 FY | 1.4 Billion CHF | 8.89% |
| 2018 Q3 | 1.52 Billion CHF | 35.35% |
| 2018 Q2 | 1.12 Billion CHF | -5.95% |
| 2018 Q4 | 1.4 Billion CHF | -7.89% |
| 2017 Q1 | 812.98 Million CHF | 0.0% |
| 2017 FY | 1.29 Billion CHF | 41.17% |
| 2017 Q4 | 1.29 Billion CHF | 13.79% |
| 2017 Q3 | 1.13 Billion CHF | -4.8% |
| 2017 Q2 | 1.19 Billion CHF | 46.7% |
| 2016 FY | 915.12 Million CHF | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Addex Therapeutics Ltd | 4.64 Million CHF | -10673.368% |
| BB Biotech AG | 2.63 Billion CHF | 81.04% |
| Basilea Pharmaceutica AG | 173.28 Million CHF | -188.533% |
| Evolva Holding SA | 9.82 Million CHF | -4987.361% |
| Kuros Biosciences AG | 75.9 Million CHF | -558.704% |
| Molecular Partners AG | 198.35 Million CHF | -152.075% |
| Relief Therapeutics Holding AG | 76.39 Million CHF | -554.531% |
| Santhera Pharmaceuticals Holding AG | 109.62 Million CHF | -356.08% |